CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 2,438 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01185392
NCT01185392N/ACompleted
CompareCT.gov

European Cardiac Resynchronisation Therapy Survey

Helse Stavanger HF·observational·Posted Aug 19, 2010·Updated Jun 27, 2024

In Brief

An observational study for Heart Failure. Completed, enrolled 2,438 participants.

Detailed Summary

The European CRT survey represents a joint initiative between two ESC associations; the Heart Failure Association and the European Heart Rhythm Association. The survey will be performed in collaboration with The Institute für Herzinfarktforschung in Ludwigshafen which will handle the data collection and data analysis.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure
Countries--
CollaboratorsBoston Scientific Corporation, Medtronic, Abbott Medical Devices, Biotronik SE & Co. KG, LivaNova, Roche Diagnostic Ltd.

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedAug 19, 2010
Enrollment StartNov 1, 2008
Primary CompletionJun 1, 2009
Study CompletionJan 1, 2012
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 15.9 years ago